MedTech CoRE Annual Conference 2016 Speakers
Colart Miles is cofounder of Velox Innovation, and is helping a number of leading Kiwi companies accelerate their product development and increase value given to customers. He has a passion for building beautiful businesses, and his company recently helped to develop Callaghan Innovation’s Driving Innovation programme and are the current delivery partner.
Colart has a solid track record of delivery with a number of iconic New Zealand companies including WorldVision, Downer, Serato, Fisher & Paykel Healthcare, Air New Zealand, NZME and Ooooby. As a specialist in business design, disruption, value-driven techniques (like Agile and Lean) and innovation, Colart’s career has spanned a variety of industries in Europe, the U.S. and New Zealand. He holds an MBA and a BSc in Computer Science, and regularly mentors for business accelerators and startup weekends.
Richard is a multi-award winning inventor and engineer and roboticist, in the past Richard has held a range of directorships and other senior positions in a range of engineering, military and medical businesses. His previous enterprise, Rex Bionics, listed on the UK AIM stock exchange in an IPO in 2014.
Richard’s latest venture, Exsurgo Rehab, has been created with an experienced team of experience medical device and clinical personnel to deliver technology solutions that could alleviate the suffering and improve the quality of life of potentially millions of stroke sufferers world-wide. Exsurgo Rehab devices provide targeted and individualized movement therapy sessions that offer cost effective & efficient therapy with improved patient outcomes.
Matthew currently holds the position of Professor in Gerontology across Waikato DHB and the University of Auckland. He has a strong working relationship with multiple DHBs, having reviewed or supported implementation of services across many. He has been heavily involved in service development around older person health, disability and rehabilitation for over 20 years and has been central to a number of key national initiatives including development of supported discharge (START, Waikato DHB and CREST, Canterbury DHB) and alternative models of community services. His current work includes profiling at risk populations and identifying better ways of targeting services to support them.
Matthew has an active interest in health technology having lead the first full scale trial of telemedicine in New Zealand (ASSET) and more recently worked with Callaghan around the establishment of the Institute of Healthy Ageing Standing Trial; a joint DHB/Callaghan initiative to support the testing and development of health technology in the real world. Matthew holds governance board membership across interRAI New Zealand and the Institute of Healthy Ageing. Matthew has won in excess of $20 million in external research funds and has over 100 publications relating to older people, disability and technology.
Stefan co-founded the Brain-Inspired Computing Research program of IBM Research – Australia in 2015 and now leads it as an IBM Research Staff Member and Honorary Principal Research Fellow at the Centre for Neural Engineering at the University of Melbourne. His team spearheads an effort to employ IBM’s recently introduced cognitive TrueNorth chip to develop artificial intelligence-enabled biomedical and healthcare solutions at the intersection of neuroscience and neuromorphic computing. Since joining IBM Research in 2008, Stefan has worked on biotechnology and nanotechnology research projects in New York at IBM AlbanyNanotech and the IBM T.J. Watson Research Center as well as at IBM Research - Australia.
Stefan has authored and co-authored 40 technical publications, is an inventor on 25 issued patents and has more than 20 patents pending. His work has been featured in WIREDMagazine, Popular Science, Scientific American, TechTimes, Engadget and Fast Company amongst others. He holds a PhD in EECS from the Technical University Munich and an Honours Masters Certificate in Technology Management from the Center for Digital Technology and Management.
Balaji is a medical imaging inventor/scientist and entrepreneur. His roles include Senior Imaging Scientist at the Institute of Nuclear Medicine, University College London; Director of New Business at Feedback Plc; and CEO of TexRAD Ltd. TexRAD is an innovative quantitative imaging biomarker using patented texture analysis technology obtained from routinely acquired diagnostic images. Killer-applications include prognosis, disease-severity assessment, and response to conventional and novel drugs predominantly in oncology focussed on "Precision/Personalised-Medicine". He is also a Director of Prostate Checker Ltd and Director of Stone Checker Software Ltd.
Balaji has authored and co-authored 41 scientific publications. He completed his PhD in Biomedical Engineering (specializing in Medical Image Processing) from the University of Sussex and currently also holds an Honorary position with the Brighton & Sussex Medical School, University of Sussex, UK.
MC: Duncan Babbage
Duncan Babbage, PhD, is Director of the AUT Centre for eHealth and an Associate Professor in Rehabilitation in the Centre for Person Centred Research at Auckland University of Technology, New Zealand. Based on broad base of practice in clinical psychology, Duncan’s research examines the use of technology in healthcare, particularly mobile technologies, as well as neuropsychological rehabilitation after brain injury. His focus is on implementation science and translation of research into practice.